FibroGen Stock Forward View - Simple Exponential Smoothing
| FGENDelisted Stock | USD 9.22 0.29 3.05% |
FibroGen Stock outlook is based on your current time horizon.
As of today, the value of RSI of FibroGen's share price is approaching 46. This usually indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling FibroGen, making its price go up or down. Momentum 46
Impartial
Oversold | Overbought |
Using FibroGen hype-based prediction, you can estimate the value of FibroGen from the perspective of FibroGen response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Exponential Smoothing forecasted value of FibroGen on the next trading day is expected to be 9.22 with a mean absolute deviation of 0.25 and the sum of the absolute errors of 14.98. FibroGen after-hype prediction price | USD 9.21 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
FibroGen |
FibroGen Additional Predictive Modules
Most predictive techniques to examine FibroGen price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for FibroGen using various technical indicators. When you analyze FibroGen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
FibroGen Simple Exponential Smoothing Price Forecast For the 21st of February
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of FibroGen on the next trading day is expected to be 9.22 with a mean absolute deviation of 0.25, mean absolute percentage error of 0.15, and the sum of the absolute errors of 14.98.Please note that although there have been many attempts to predict FibroGen Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that FibroGen's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
FibroGen Stock Forecast Pattern
| Backtest FibroGen | FibroGen Price Prediction | Research Analysis |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of FibroGen stock data series using in forecasting. Note that when a statistical model is used to represent FibroGen stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 114.3626 |
| Bias | Arithmetic mean of the errors | 0.0303 |
| MAD | Mean absolute deviation | 0.2497 |
| MAPE | Mean absolute percentage error | 0.0266 |
| SAE | Sum of the absolute errors | 14.98 |
Predictive Modules for FibroGen
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as FibroGen. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of FibroGen's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
FibroGen After-Hype Price Density Analysis
As far as predicting the price of FibroGen at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in FibroGen or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of FibroGen, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
FibroGen Estimiated After-Hype Price Volatility
In the context of predicting FibroGen's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on FibroGen's historical news coverage. FibroGen's after-hype downside and upside margins for the prediction period are 4.43 and 13.99, respectively. We have considered FibroGen's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
FibroGen is slightly risky at this time. Analysis and calculation of next after-hype price of FibroGen is based on 3 months time horizon.
FibroGen Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as FibroGen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading FibroGen backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with FibroGen, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.32 | 4.78 | 0.01 | 0.00 | 2 Events / Month | 7 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
9.22 | 9.21 | 0.11 |
|
FibroGen Hype Timeline
FibroGen is currently traded for 9.22. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of 0.0. FibroGen is forecasted to decline in value after the next headline, with the price expected to drop to 9.21. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.11%, whereas the daily expected return is currently at 0.32%. The volatility of related hype on FibroGen is about 9.223372036854776E16%, with the expected price after the next announcement by competition of 9.22. About 28.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 12.85. FibroGen had not issued any dividends in recent years. The entity had 1:25 split on the 17th of June 2025. Given the investment horizon of 90 days the next forecasted press release will be in a few days. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued.FibroGen Related Hype Analysis
Having access to credible news sources related to FibroGen's direct competition is more important than ever and may enhance your ability to predict FibroGen's future price movements. Getting to know how FibroGen's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how FibroGen may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| KZR | Kezar Life Sciences | (0.02) | 8 per month | 1.00 | 0.06 | 1.93 | (1.27) | 7.79 | |
| TPST | Tempest Therapeutics | (0.17) | 5 per month | 0.00 | (0.18) | 7.62 | (9.19) | 52.01 | |
| ALGS | Aligos Therapeutics | 0.41 | 7 per month | 5.19 | 0.06 | 11.50 | (8.20) | 28.43 | |
| OKUR | OnKure Therapeutics | (0.14) | 6 per month | 0.00 | (0.04) | 7.76 | (6.92) | 25.44 | |
| MRSN | Mersana Therapeutics | (0.02) | 22 per month | 2.27 | 0.13 | 7.25 | (6.26) | 210.61 | |
| XFOR | X4 Pharmaceuticals | 0.01 | 7 per month | 0.00 | (0.05) | 7.28 | (5.39) | 26.01 | |
| PDSB | PDS Biotechnology Corp | 0.04 | 8 per month | 0.00 | (0.07) | 8.00 | (7.14) | 27.78 | |
| CELU | Celularity | (0.01) | 9 per month | 0.00 | (0.04) | 11.11 | (8.97) | 26.97 | |
| XLO | Xilio Development | 0.01 | 7 per month | 0.00 | (0.11) | 4.23 | (5.45) | 15.41 | |
| ATNM | Actinium Pharmaceuticals | (0.11) | 5 per month | 0.00 | (0.04) | 6.29 | (5.43) | 20.75 |
FibroGen Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with FibroGen stock to make a market-neutral strategy. Peer analysis of FibroGen could also be used in its relative valuation, which is a method of valuing FibroGen by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
FibroGen Market Strength Events
Market strength indicators help investors to evaluate how FibroGen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading FibroGen shares will generate the highest return on investment. By undertsting and applying FibroGen stock market strength indicators, traders can identify FibroGen entry and exit signals to maximize returns.
FibroGen Risk Indicators
The analysis of FibroGen's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in FibroGen's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting fibrogen stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.66 | |||
| Standard Deviation | 4.1 | |||
| Variance | 16.8 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for FibroGen
The number of cover stories for FibroGen depends on current market conditions and FibroGen's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that FibroGen is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about FibroGen's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
FibroGen Short Properties
FibroGen's future price predictability will typically decrease when FibroGen's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of FibroGen often depends not only on the future outlook of the potential FibroGen's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. FibroGen's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 100 M | |
| Cash And Short Term Investments | 50.5 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in FibroGen Stock
If you are still planning to invest in FibroGen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FibroGen's history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges |